tiprankstipranks
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
US Market
PLRX
Pliant Therapeutics
RESEARCH TOOLSreports
Want to see PLRX full AI Analyst Report?

Pliant Therapeutics (PLRX) Income Statement

515 Followers

Pliant Therapeutics Income Statement

Last quarter (Q4 2025), Pliant Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Pliant Therapeutics's net income was $-23.58M. See Pliant Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 1.58M$ 9.69M$ 7.57M
Gross Profit
$ -1.70M$ 0.00$ 1.58M$ 9.69M$ 7.57M
Operating Expenses
$ 148.38M$ 228.37M$ 185.72M$ 136.88M$ 105.11M
Depreciation and Amortization
$ 1.70M$ 2.13M$ 1.84M$ 3.68M$ 1.53M
EBITDA
$ -148.38M$ -205.16M$ -158.23M$ -118.85M$ -95.73M
Operating Income
$ -150.07M$ -228.37M$ -184.15M$ -127.20M$ -97.53M
Other Income/Expenses
$ 729.00K$ 18.06M$ 22.81M$ 3.88M$ 272.00K
Pretax Income
$ -149.34M$ -210.30M$ -161.34M$ -123.32M$ -97.26M
Net Income
$ -149.34M$ -210.30M$ -161.34M$ -123.32M$ -97.26M
Per Share Metrics
Basic EPS
$ -2.43$ -3.47$ -2.75$ -2.94$ -2.71
Diluted EPS
$ -2.43$ -3.47$ -2.75$ -2.94$ -2.71
Weighted Average Shares Outstanding
 61.37M 60.54M 58.72M 42.02M 35.85M
Weighted Average Shares Outstanding (Diluted)
 61.37M 60.54M 58.72M 42.02M 35.85M
Currency in USD

Pliant Therapeutics Earnings and Revenue History